{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:00:01Z","timestamp":1771012801388,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T00:00:00Z","timestamp":1269907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T00:00:00Z","timestamp":1269907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10637-010-9414-6","type":"journal-article","created":{"date-parts":[[2010,3,29]],"date-time":"2010-03-29T05:57:10Z","timestamp":1269842230000},"page":"963-970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer"],"prefix":"10.1007","volume":"29","author":[{"given":"Donald A.","family":"Richards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Loesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetislava J.","family":"Vukelja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Nieves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwatoyin O.","family":"Shonukan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Datchen F.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,30]]},"reference":[{"key":"9414_CR1","first-page":"1116","volume":"57","author":"C Shih","year":"1997","unstructured":"Shih C, Chen VJ, Gossett LS et al (1997) LY231514, a pyrrolo[2, 3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res 57:1116\u20131123","journal-title":"Cancer Res"},{"key":"9414_CR2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1006\/jmbi.2001.4815","volume":"310","author":"X Sun","year":"2001","unstructured":"Sun X, Cross JA, Bognar AL et al (2001) Folate-binding triggers the activation of folylpolyglutamate synthetase. J Mol Biol 310:1067\u20131078","journal-title":"J Mol Biol"},{"key":"9414_CR3","first-page":"3687","volume":"6","author":"R Zhao","year":"2000","unstructured":"Zhao R, Babani S, Gao F et al (2000) The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate. Clin Cancer Res 6:3687\u20133695","journal-title":"Clin Cancer Res"},{"key":"9414_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2002.37461","volume":"29","author":"ID Goldman","year":"2002","unstructured":"Goldman ID, Zhao R (2002) Molecular, biochemical, and cellular pharmacology of pemetrexed. Semin Oncol 29:3\u201317","journal-title":"Semin Oncol"},{"key":"9414_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/sonc.2002.30764","volume":"29","author":"FV Fossella","year":"2000","unstructured":"Fossella FV, Gatzemeier U (2000) Phase I trials of pemetrexed. Semin Oncol 29:8\u201316","journal-title":"Semin Oncol"},{"key":"9414_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","volume":"42","author":"A Gabizon","year":"2003","unstructured":"Gabizon A, Shmeeda H, Barenholz Y (2003) Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet 42:419\u2013436","journal-title":"Clin Pharmacokinet"},{"key":"9414_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0169-409X(95)00023-Z","volume":"16","author":"S Zalipsky","year":"1995","unstructured":"Zalipsky S (1995) Chemistry of polyethylene glycol conjugates with biologically active molecules. Adv Drug Delivery Rev 16:157\u2013182","journal-title":"Adv Drug Delivery Rev"},{"key":"9414_CR8","unstructured":"Adriamycin (doxorubicin HCl) for injection, USP: Package insert. 10\/06 update. http:\/\/www.bedfordlabs.com\/BedfordLabsWeb\/products\/inserts\/ADR-P01.pdf"},{"key":"9414_CR9","doi-asserted-by":"publisher","first-page":"11460","DOI":"10.1073\/pnas.88.24.11460","volume":"88","author":"D Papahadjopoulos","year":"1991","unstructured":"Papahadjopoulos D, Allen TM, Gabizon A et al (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 88:11460\u201311464","journal-title":"Proc Natl Acad Sci USA"},{"key":"9414_CR10","first-page":"6551","volume":"9","author":"A Gabizon","year":"2003","unstructured":"Gabizon A, Horowitz AT, Goren D et al (2003) In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin Cancer Res 9:6551\u20136559","journal-title":"Clin Cancer Res"},{"key":"9414_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.0.CO;2-1","volume":"86","author":"Z Symon","year":"1999","unstructured":"Symon Z, Peyser A, Tzemach D et al (1999) Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer 86:72\u201378","journal-title":"Cancer"},{"key":"9414_CR12","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1200\/JCO.2008.19.2963","volume":"27","author":"DS Miller","year":"2009","unstructured":"Miller DS, Blessing JA, Krasner CN et al (2009) Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group. J Clin Oncol 27:2686\u20132691","journal-title":"J Clin Oncol"},{"key":"9414_CR13","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.ejca.2008.12.013","volume":"45","author":"I Vergote","year":"2009","unstructured":"Vergote I, Calvert H, Kania M et al (2009) A randomized, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer. Eur J Cancer 45:1415\u20131423","journal-title":"Eur J Cancer"},{"key":"9414_CR14","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1200\/JCO.2007.11.0593","volume":"25","author":"DS Hsu","year":"2007","unstructured":"Hsu DS, Balakumaran BS, Acharya CR et al (2007) Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 25:4350\u20134357","journal-title":"J Clin Oncol"},{"key":"9414_CR15","first-page":"55","volume":"26","author":"BA Teicher","year":"1999","unstructured":"Teicher BA, Alvarez E, Liu P et al (1999) MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma. Semin Oncol 26:55\u201362","journal-title":"Semin Oncol"},{"key":"9414_CR16","first-page":"1016","volume":"6","author":"BA Teicher","year":"2000","unstructured":"Teicher BA, Chen V, Shih C et al (2000) Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts. Clin Cancer Res 6:1016\u20131023","journal-title":"Clin Cancer Res"},{"key":"9414_CR17","first-page":"3209","volume":"21","author":"M Schultz","year":"2001","unstructured":"Schultz M, Dempsey JA (2001) Sequence dependence of Alimta (LY231514, MTA) combined with doxorubicin in ZR-75-1 human breast carcinoma cells. Anticancer Res 21:3209\u20133214","journal-title":"Anticancer Res"},{"key":"9414_CR18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3816\/CGC.2002.n.005","volume":"1","author":"KA Harris","year":"2002","unstructured":"Harris KA, Harney E, Small EJ (2002) Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer. Clin Prostate Cancer 1:37\u201341","journal-title":"Clin Prostate Cancer"},{"key":"9414_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/sonc.2002.37474","volume":"29","author":"JA O'Shaughnessy","year":"2002","unstructured":"O'Shaughnessy JA (2002) Pemetrexed: an active new agent for breast cancer. Semin Oncol 29:57\u201362","journal-title":"Semin Oncol"},{"issue":"Suppl. 1","key":"9414_CR20","first-page":"S133","volume":"76","author":"JA O'Shaughnessy","year":"2002","unstructured":"O'Shaughnessy JA, Liepa AM, Nguyen B (2002) Symptom improvement with pemetrexed for heavily pre-treated patients with advanced breast cancer. Breast Cancer Res Treat 76(suppl 1):S133","journal-title":"Breast Cancer Res Treat"},{"key":"9414_CR21","unstructured":"National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) v3.0. 8\/06 update. http:\/\/ctep.cancer.gov\/reporting\/ctc.html"},{"key":"9414_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"9414_CR23","unstructured":"Alimta\u00ae (pemetrexed disodium) injection, powder, lyophilized, for solution for intravenous use. Package insert. 7\/09 update. http:\/\/pi.lilly.com\/us\/alimta-pi.pdf"},{"key":"9414_CR24","unstructured":"Doxil\u00ae (doxorubicin HCl liposome injection) for intravenous infusion: Full prescribing information. 5\/07 update. http:\/\/www.orthobiotech.com\/orthobiotech\/shared\/OBI\/PI\/DOXIL_PI.pdf"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-010-9414-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9414-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:56:19Z","timestamp":1678510579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-010-9414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,30]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9414"],"URL":"https:\/\/doi.org\/10.1007\/s10637-010-9414-6","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,30]]},"assertion":[{"value":"26 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}